Cargando…
Advances in Targeted Cancer Therapy
There have been tremendous advances in our understanding of molecular and tumor biology during the past few years. In the field of cancer therapeutics, it is expected that cytotoxic drug approaches will be gradually replaced with treatments based on biological targeted approaches. Hopefully these ne...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Basel :
Birkhäuser Basel : Imprint: Birkhäuser,
2005.
|
| Edición: | 1st ed. 2005. |
| Colección: | Progress in Drug Research,
63 |
| Temas: | |
| Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Dawn of a new era in molecular cancer therapeutics
- Obtacles and opportunities in the clinical development of targeted therapeutics
- Tumor models for preclinical development of targeted agents
- Angiogenesis inhibitors: What is the clinical future?
- Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy
- Cell survival signaling during apoptosis: Implications in drug resistance and anti-cancer therapeutic development
- Targeted histone deacetylase inhibition for cancer prevention and therapy
- Inhibitors of cyclin-dependent kinase modulators for cancer therapy
- Targeting cyclooxygenase-2 for cancer prevention and treatment
- Antisense approaches in drug discovery and development
- Preclinical development of Alimta™ (Pemetrexed, LY231514), a multitargeted antifolate.